News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Varadan Anand
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/30/2023 |
4
| Varadan Anand (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 1,700 options to buy
@ $3.99, valued at
$6.8k
|
|
| 01/28/2022 |
4
| Varadan Anand (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 22,100 options to buy
@ $0.3701, valued at
$8.2k
|
|
| 08/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2020 |
4
| Varadan Anand (EVP, Chief Commerical Officer) has filed a Form 4 on CHIASMA, INC|
Txns:
| Granted 425,000 options to buy
@ $4.43, valued at
$1.9M
|
|
| 04/22/2020 |
3
| Varadan Anand (EVP, Chief Commerical Officer) has filed a Form 3 on CHIASMA, INC |
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2018 |
4
| Varadan Anand (EVP, Chief Commercial Officer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 150,000 options to buy
@ $18.68, valued at
$2.8M
|
|
| 06/25/2018 |
3
| Varadan Anand (EVP, Chief Commercial Officer) has filed a Form 3 on Karyopharm Therapeutics Inc. |
|
|